Brain Health Together: Development and Pilot Test

Completed

• Conditions: Cognitive Impairment; Subjective Cognitive Decline; Mild Cognitive Impairment (MCI)

• Registration Number: NCT06914947
• Lead Sponsor: University of California, San Francisco

Brief Summary

The objectives of this study were to develop and pilot-test Brain Health Together (BHT), a 12-week, virtual-group program that combines our evidence-based, mind-body, group movement program with brain health education and coaching to reduce dementia risk through targeting modifiable risk factors among older adults with cognitive impairment.

Detailed Description

Our study design for developing, pilot-testing, and refining the BHT program was conducted in 2 phases. In Phase 1, the investigators used a human-centered design approach to deeply understand and respond to the needs, challenges, and motivations of potential users when developing the BHT program. In Phase 2, the investigators performed a pilot study to refine BHT program content and assess acceptability and potential feasibility.

Study Timeline

• Study Start: 2021-09-30
• Primary Completion: 2022-09-06
• Study Completion: 2022-10-11
• Status Verified: 2025-04
• Study First Submitted: 2025-04-04
• Study First Submitted QC: 2025-04-04
• Study First Posted: 2025-04-07
• Last Update Submitted: 2025-04-07
• Last Update Posted: 2025-04-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• Mild cognitive impairment or subjective cognitive decline
• English language proficiency
• Active participants in Moving Together (Intervention Arm)

Exclusion Criteria

• wheelchair user
• medical condition, physical limitation, visual or hearing impairment or psychiatric condition that could affect ability to participate in a virtually-delivered multicomponent intervention
• moderate/severe dementia severity

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intervention Feasibility	12 weeks	To examine feasibility, the investigators tracked participant attendance, calculated as the mean±standard deviation (SD) of sessions completed by each participant.
Acceptability	12 weeks	The investigators asked participants how likely they are to recommend BHT to others on a scale from 0 (not at all likely) to 10 (extremely likely) and calculated a net promoter score as the percentage of promoters (scores of 9 or 10) minus the percentage of detractors (scores of 0 to 6).

Trial Locations

Locations (1)

University of California, San Francisco; 🇺🇸 San Francisco, California, United States